Journal of Clinical Pharmacology

Papers
(The H4-Index of Journal of Clinical Pharmacology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Application of PBPK Modeling and Simulation for Regulatory Decision Making and Its Impact on US Prescribing Information: An Update on the 2018‐2019 Submissions to the US FDA's Office of Clinical Pharm78
PEG That Reaction: A Case Series of Allergy to Polyethylene Glycol55
MDMA‐Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta‐Analysis53
Baricitinib: From Rheumatoid Arthritis to COVID‐1941
The Epidemiology of Drug Abuse37
Pharmacology of Drugs Used as Stimulants32
Chimeric Antigen Receptor T Cell Therapies: A Review of Cellular Kinetic‐Pharmacodynamic Modeling Approaches31
Differential Binding of Sarilumab and Tocilizumab to IL‐6Rα and Effects of Receptor Occupancy on Clinical Parameters31
Continued Risk of Dietary Supplements Adulterated With Approved and Unapproved Drugs: Assessment of the US Food and Drug Administration's Tainted Supplements Database 2007 Through 202130
Natural History and Real‐World Data in Rare Diseases: Applications, Limitations, and Future Perspectives30
Effects of Hepatic Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites30
Neurological Immune‐Related Adverse Events After COVID‐19 Vaccination: A Systematic Review27
Applications of Physiologically Based Pharmacokinetic Modeling of Rivaroxaban—Renal and Hepatic Impairment and Drug‐Drug Interaction Potential23
Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis‐Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry22
Clinical Pharmacology of Electronic Nicotine Delivery Systems (ENDS): Implications for Benefits and Risks in the Promotion of the Combusted Tobacco Endgame21
Gabapentinoid Pharmacology in the Context of Emerging Misuse Liability21
Antiretrovirals for Prophylaxis Against COVID‐19: A Comprehensive Literature Review20
Pharmacogenomics and Morphine19
A Physiological Approach to Pharmacokinetics in Chronic Kidney Disease19
Fetal Arrhythmia Diagnosis and Pharmacologic Management19
Potential COVID‐19 Therapeutic Agents and Vaccines: An Evidence‐Based Review19
0.042101144790649